Bilous M - Search Results

1

Carcinomas of the renal pelvis associated with smoking and phenacetin abuse: p53 mutations and polymorphism of carcinogen-metabolising enzymes.

Bringuier PP, McCredie M, Sauter G, Bilous M, Stewart J, Mihatsch MJ, Kleihues P, Ohgaki H. Bringuier PP, et al. Among authors: bilous m. Int J Cancer. 1998 Oct 23;79(5):531-6. doi: 10.1002/(sici)1097-0215(19981023)79:5<531::aid-ijc15>3.0.co;2-4. Int J Cancer. 1998. PMID: 9761125

2

Adequacy of histopathology reports for breast cancer in New South Wales.

Bilous M, McCredie M, Porter L. Bilous M, et al. Pathology. 1995 Oct;27(4):306-11. doi: 10.1080/00313029500169193. Pathology. 1995. PMID: 8771145

3

Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.

Leong C, Boyages J, Jayasinghe UW, Bilous M, Ung O, Chua B, Salisbury E, Wong AY. Leong C, et al. Among authors: bilous m. Cancer. 2004 May 1;100(9):1823-32. doi: 10.1002/cncr.20153. Cancer. 2004. PMID: 15112262 Free article.

4

An audit of breast cancer pathology reporting in Australia in 1995.

Kricker A, Armstrong B, Smith C, Bilous M, Camaris C, Mayer A, Psarianos T. Kricker A, et al. Among authors: bilous m. Br J Cancer. 1999 May;80(3-4):563-8. doi: 10.1038/sj.bjc.6690392. Br J Cancer. 1999. PMID: 10408867 Free PMC article.

5

Intraoperative imprint cytology of sentinel lymph nodes in breast cancer: initial experience and lessons learnt in establishing a new practice.

Pathmanathan N, Jones W, Salisbury E, Bilous M. Pathmanathan N, et al. Among authors: bilous m. Pathology. 2006 Aug;38(4):321-7. doi: 10.1080/00313020600820922. Pathology. 2006. PMID: 16916721

6

Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry.

Bilous M, Morey A, Armes J, Cummings M, Francis G. Bilous M, et al. Pathology. 2006 Apr;38(2):120-4. doi: 10.1080/00313020600561518. Pathology. 2006. PMID: 16581651

7

Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program.

Morey AL, Brown B, Farshid G, Fox SB, Francis GD, McCue G, von Neumann-Cosel V, Bilous M. Morey AL, et al. Among authors: bilous m. Pathology. 2016 Oct;48(6):535-42. doi: 10.1016/j.pathol.2016.05.007. Epub 2016 Aug 25. Pathology. 2016. PMID: 27567228

8

HER2 testing recommendations in Australia.

Bilous M; HER2 Testing Advisory Board. Bilous M, et al. Pathology. 2001 Nov;33(4):425-7. doi: 10.1080/00313020120083133. Pathology. 2001. PMID: 11827407 Review.

9

Predicting the HER2 status of breast cancer from basic histopathology data: an analysis of 1500 breast cancers as part of the HER2000 International Study.

Bilous M, Ades C, Armes J, Bishop J, Brown R, Cooke B, Cummings M, Farshid G, Field A, Morey A, McKenzie P, Raymond W, Robbins P, Tan L. Bilous M, et al. Breast. 2003 Apr;12(2):92-8. doi: 10.1016/s0960-9776(02)00273-4. Breast. 2003. PMID: 14659337

10

Ductal carcinoma in situ. Part 2: Treatment.

Delaney G, Ung O, Cahill S, Bilous M, Boyages J. Delaney G, et al. Among authors: bilous m. Aust N Z J Surg. 1997 Apr;67(4):157-65. doi: 10.1111/j.1445-2197.1997.tb01931.x. Aust N Z J Surg. 1997. PMID: 9137153 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters